Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CC
CC logo

CC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Chemours Co (CC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
21.770
1 Day change
-1.14%
52 Week Range
28.670
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Chemours Co (CC) does not present a strong buy opportunity for a beginner investor with a long-term focus at this time. While there are some positive catalysts, the lack of significant recent news, neutral insider and hedge fund activity, and no strong trading signals suggest holding off on an immediate investment.

Technical Analysis

The technical indicators show a mixed picture. The MACD is positive and expanding, indicating bullish momentum. The RSI is neutral at 50.378, suggesting no clear overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading near its pivot level of 21.463, with resistance at 22.839 and support at 20.088.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
4

Positive Catalysts

  • Analysts have raised price targets recently, with several maintaining Buy or Outperform ratings. The company is expected to benefit from strong refrigerant demand and potential price increases in titanium dioxide in the second half of the year.

Neutral/Negative Catalysts

  • The stock has shown a downward trend in the regular market (-1.14%) and post-market (-0.05%) changes. There is no significant news or event-driven catalysts, and hedge fund and insider activity remain neutral. Additionally, the stock has a 30% chance to decline in the short term based on similar candlestick patterns.

Financial Performance

No financial data available for assessment.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are generally positive, with multiple firms raising price targets to the $25-$30 range and maintaining Buy or Outperform ratings. However, some investors are cautious about Chemours' maintained FY26 guidance, which is seen as weaker compared to peers.

Wall Street analysts forecast CC stock price to fall
7 Analyst Rating
Wall Street analysts forecast CC stock price to fall
5 Buy
2 Hold
0 Sell
Moderate Buy
Current: 22.020
sliders
Low
13
Averages
16.14
High
19
Current: 22.020
sliders
Low
13
Averages
16.14
High
19
Alembic Global
NULL -> Overweight
maintain
$24 -> $30
AI Analysis
2026-05-13
Reason
Alembic Global
Price Target
$24 -> $30
AI Analysis
2026-05-13
maintain
NULL -> Overweight
Reason
Alembic Global raised the firm's price target on Chemours to $30 from $24 and keeps an Overweight rating on the shares.
Morgan Stanley
Vincent Andrews
Equal Weight
maintain
$17 -> $21
2026-05-11
Reason
Morgan Stanley
Vincent Andrews
Price Target
$17 -> $21
2026-05-11
maintain
Equal Weight
Reason
Morgan Stanley analyst Vincent Andrews raised the firm's price target on Chemours to $21 from $17 and keeps an Equal Weight rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CC
Unlock Now

People Also Watch